354 related articles for article (PubMed ID: 15240608)
1. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men.
Malkin CJ; Pugh PJ; Jones RD; Kapoor D; Channer KS; Jones TH
J Clin Endocrinol Metab; 2004 Jul; 89(7):3313-8. PubMed ID: 15240608
[TBL] [Abstract][Full Text] [Related]
2. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life.
Malkin CJ; Pugh PJ; Morris PD; Kerry KE; Jones RD; Jones TH; Channer KS
Heart; 2004 Aug; 90(8):871-6. PubMed ID: 15253956
[TBL] [Abstract][Full Text] [Related]
3. The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes.
Kapoor D; Clarke S; Stanworth R; Channer KS; Jones TH
Eur J Endocrinol; 2007 May; 156(5):595-602. PubMed ID: 17468196
[TBL] [Abstract][Full Text] [Related]
4. Inverse relationship between serum levels of interleukin-1beta and testosterone in men with stable coronary artery disease.
Nettleship JE; Pugh PJ; Channer KS; Jones T; Jones RD
Horm Metab Res; 2007 May; 39(5):366-71. PubMed ID: 17533579
[TBL] [Abstract][Full Text] [Related]
5. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy.
Lanfranco F; Zitzmann M; Simoni M; Nieschlag E
Clin Endocrinol (Oxf); 2004 Apr; 60(4):500-7. PubMed ID: 15049966
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil improves sleep-related erections in hypogonadal men: evidence from a randomized, placebo-controlled, crossover study of a synergic role for both testosterone and sildenafil on penile erections.
Rochira V; Balestrieri A; Madeo B; Granata AR; Carani C
J Androl; 2006; 27(2):165-75. PubMed ID: 16278367
[TBL] [Abstract][Full Text] [Related]
7. Change in cytokine levels after administration of saikokaryuukotsuboreito or testosterone in patients with symptoms of late-onset hypogonadism.
Tsujimura A; Miyagawa Y; Okuda H; Yamamoto K; Fukuhara S; Nakayama J; Takao T; Nonomura N; Okuyama A
Aging Male; 2011 Mar; 14(1):76-81. PubMed ID: 20712429
[TBL] [Abstract][Full Text] [Related]
8. Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels.
Leder BZ; Rohrer JL; Rubin SD; Gallo J; Longcope C
J Clin Endocrinol Metab; 2004 Mar; 89(3):1174-80. PubMed ID: 15001605
[TBL] [Abstract][Full Text] [Related]
9. The effect of androgens on lipids.
Monroe AK; Dobs AS
Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):132-9. PubMed ID: 23422242
[TBL] [Abstract][Full Text] [Related]
10. Effect of aromatase inhibition on lipids and inflammatory markers of cardiovascular disease in elderly men with low testosterone levels.
Dougherty RH; Rohrer JL; Hayden D; Rubin SD; Leder BZ
Clin Endocrinol (Oxf); 2005 Feb; 62(2):228-35. PubMed ID: 15670201
[TBL] [Abstract][Full Text] [Related]
11. Testosterone replacement therapy improves insulin sensitivity and decreases high sensitivity C-reactive protein levels in hypogonadotropic hypogonadal young male patients.
Wu XY; Mao JF; Lu SY; Zhang Q; Shi YF
Chin Med J (Engl); 2009 Dec; 122(23):2846-50. PubMed ID: 20092788
[TBL] [Abstract][Full Text] [Related]
12. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
13. Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency.
Corrales JJ; Almeida M; Burgo R; Mories MT; Miralles JM; Orfao A
J Endocrinol; 2006 Jun; 189(3):595-604. PubMed ID: 16731790
[TBL] [Abstract][Full Text] [Related]
14. Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men.
Maggio M; Basaria S; Ble A; Lauretani F; Bandinelli S; Ceda GP; Valenti G; Ling SM; Ferrucci L
J Clin Endocrinol Metab; 2006 Jan; 91(1):345-7. PubMed ID: 16263825
[TBL] [Abstract][Full Text] [Related]
15. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.
Elgzyri T; Castenfors J; Hägg E; Backman C; Thorén M; Bramnert M
Clin Endocrinol (Oxf); 2004 Jul; 61(1):113-22. PubMed ID: 15212653
[TBL] [Abstract][Full Text] [Related]
16. Systemic and local cytokine patterns during total hip surgery.
Clementsen T; Krohn CD; Reikerås O
Scand J Clin Lab Invest; 2006; 66(6):535-42. PubMed ID: 17000561
[TBL] [Abstract][Full Text] [Related]
17. Effects of testosterone replacement on HDL subfractions and apolipoprotein A-I containing lipoproteins.
Tan KC; Shiu SW; Pang RW; Kung AW
Clin Endocrinol (Oxf); 1998 Feb; 48(2):187-94. PubMed ID: 9579231
[TBL] [Abstract][Full Text] [Related]
18. Effects of testosterone replacement in hypogonadal men.
Snyder PJ; Peachey H; Berlin JA; Hannoush P; Haddad G; Dlewati A; Santanna J; Loh L; Lenrow DA; Holmes JH; Kapoor SC; Atkinson LE; Strom BL
J Clin Endocrinol Metab; 2000 Aug; 85(8):2670-7. PubMed ID: 10946864
[TBL] [Abstract][Full Text] [Related]
19. Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory.
Khera M; Bhattacharya RK; Blick G; Kushner H; Nguyen D; Miner MM
J Urol; 2011 Sep; 186(3):1005-11. PubMed ID: 21788049
[TBL] [Abstract][Full Text] [Related]
20. Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study.
Kalinchenko SY; Tishova YA; Mskhalaya GJ; Gooren LJ; Giltay EJ; Saad F
Clin Endocrinol (Oxf); 2010 Nov; 73(5):602-12. PubMed ID: 20718771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]